Staphysagria (BrandStorm HBC)


Welcome to the PulseAid listing for the Staphysagria drug offered from BrandStorm HBC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: BrandStorm HBC
NON-PROPRIETARY NAME: DELPHINIUM STAPHISAGRIA SEED
SUBSTANCE NAME: DELPHINIUM STAPHISAGRIA SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: SUBLINGUAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-11-30
END MARKETING DATE: 2019-07-22


Staphysagria HUMAN OTC DRUG Details:

Item DescriptionStaphysagria from BrandStorm HBC
LABELER NAME: BrandStorm HBC
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/1)
START MARKETING DATE: 2011-11-30
END MARKETING DATE: 2019-07-22
PRODUCT ID: 76472-1164_689a08d8-aff4-4a49-be69-c677bf57bd0c
PRODUCT NDC: 76472-1164
APPLICATION NUMBER:

Other DELPHINIUM STAPHISAGRIA SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BrandStorm HBCStaphysagria
Energique, Inc.Staphysagria
Laboratoires BoironStaphysagria
Natural Health SupplySkin Eruptions
Paramesh Banerji Life Sciences LLCStaphysagria 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncSTAPHYSAGRIA
Seroyal USASTAPHYSAGRIA
STANDARD HOMEOPATHIC COMPANYSTAPHYSAGRIA
Washington Homeopathic ProductsStaphysagria Kit Refill